Supply Notification: H2-antagonists (Cimetidine, Famotidine and Nizatidine) – Update

Supply Notification: H2-antagonists (Cimetidine, Famotidine and Nizatidine) – Update

June 25, 2020

Update (25/06/2020): resupply dates now expected:

  • Famotidine 20mg tablets have limited availability with no confirmed date of next supply (Tilomed)and August 2020(Teva) 
  • Famotidine 40mg tablets have limited availability, resupply to be confirmed (Tilomed) w/c 22nd June 2020 (Teva)
  • Cimetidine 200mg tablets are in stock (Ennogen) no confirmed resupply date (Medreich)
  • Cimetidine 400mg tablets are out of stock until June 2021 (Ennogen) no confirmed resupply date (Medreich)
  • Cimetidine 800mg tablets are in stock (Ennogen) no confirmed resupply date (Medreich)
  • Nizatidine 150mg tablets: End of July 2020 (Mylan) No confirmed resupply date (Medreich)
  • Nizatidine 300mg tablets: End of June 2020 (Mylan) No confirmed resupply date (Medreich)

Department of Health and Social Care (DHSC) has issued a medicine supply notification for H2-antagonists (Cimetidine, Famotidine and Nizatidine)

Suppliers of Cimetidine, Famotidine and Nizatidine have reported an increase in demand, which has contributed to short term shortages of Cimetidine 200mg tablets, Famotidine 20mg tablets, and Nizatidine 150mg and 300mg tablets.

  • Famotidine 20mg tablets are out of stock until the end of December 2019.
  • Cimetidine 200mg tablets are out of stock until the end of January 2020.
  • Nizatidine 150mg and 300mg tablets are out of stock until February 2020.

The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need  an NHS email address. Once set up and logged in, you will be able to access it online.



Posted in:


More Latest News >